Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.
about
CXCL10 and IL-6: Markers of two different forms of intra-amniotic inflammation in preterm labor.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestationsIn vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm deliverChronic Placental Inflammation in Twin Pregnancies.Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).Interleukin-33 in the human placentaChronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.Murine model: maternal administration of stem cells for prevention of prematurity.An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birthCharacterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response.Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis.Fetal death: an extreme manifestation of maternal anti-fetal rejection.In vivo T-cell activation by a monoclonal αCD3ε antibody induces preterm labor and birth.Differential immunophenotype of macrophages in acute and chronic chorioamnionitis.Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes.Third trimester fetal demise occurring at time of delivery: correlation of autopsy findings and placental pathology with emphasis on antenatal central nervous system injury.The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Fetal central nervous system injury in third trimester stillbirth: a clinicopathologic study of 63 cases.[Pathoanatomical and clinical aspects of the placenta in preterm birth].[Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].DNA methylation profiling of acute chorioamnionitis-associated placentas and fetal membranes: insights into epigenetic variation in spontaneous preterm births
P2860
Q33845963-215ADC64-BAA8-40B8-87FA-E70ED845EC6BQ33863973-CE489468-C625-4E9F-AE55-1356AEA0AE83Q34004087-C581340A-001F-4D3C-ABBB-863149A53AF6Q34119248-9EE042E2-94BC-495A-8742-DCD38954FFFEQ34133012-D63E2ECE-D828-49AD-9A33-E7F20E3160C4Q34323437-B4BA265F-38B1-49EC-B2EF-32D7DAA8C716Q34505704-ADDB856C-B3D6-4C31-A601-BA21D2065590Q36399892-F85355E0-2487-4AD9-825A-BB6019A4C1D3Q36418431-5F22F6D0-1D2E-4301-ACD5-713B109559ADQ36455584-993549FA-A65C-4C81-975F-A60EC39F82E7Q36585708-D0077034-C772-4FC1-988B-3888F2A8F553Q36663036-FEC1FB8F-02A1-4087-ABEA-7DDAE9DEDDB1Q36755365-33A890D1-4083-40FD-BDB3-D899C1A3EBE1Q37101126-9856DDE3-5A1D-4923-8EAE-266A28F4B64DQ37612440-3DACBC0B-E777-41F3-AC4D-22F6F7277D2BQ38089828-7C76E1F3-DF83-4760-A494-C619834FCE7CQ40061417-F872C8B4-3B29-46CC-B7B2-7564DEF202CAQ40569726-D51C53AB-DCFF-4130-B59F-EDB9FF4A4E6CQ40695436-85D68CF7-B576-4000-B48E-A64095F7406BQ42670153-F1832893-BBC5-4CDC-BBC6-8D99068256C9Q44236033-11A78853-42DA-4AAC-BC56-DD23AC755EDFQ47645647-58474708-B500-4AD4-B58A-BE2C7FEDCD4FQ47832110-F120FABB-FB08-4537-AE91-2018446A4B63Q50507287-86E59F32-01CB-4B1E-811D-73C1EF178867Q53637441-F8BB7273-BAFE-47F7-AD90-7EB647CD0BE3Q58102688-1E5679B9-7559-48C5-9477-C78FE68FAAC7
P2860
Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@ast
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@en
type
label
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@ast
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@en
prefLabel
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@ast
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@en
P2093
P2860
P1433
P1476
Unexplained fetal death has a ...... leucocyte antigen antibodies.
@en
P2093
Chong Jai Kim
Faisal Qureshi
JoonHo Lee
Pooja Mittal
Sonia S Hassan
Suzanne Jacques
Wonsuk Yoo
Zhong Dong
P2860
P304
P356
10.1111/J.1365-2559.2011.04038.X
P577
2011-11-01T00:00:00Z